During the reinspection, the production conditions at the Company’s 11 sites manufacturing sterile and non-sterile medicinal products, including four new production sites, were audited.
Farmak JSC is expecting the inspection report within the term established by the Croatian laws.
The positive result of the reinspection will facilitate Farmak’s expansion to the European markets.
According to the notice of the State Service of Ukraine on Medicines and Drug Control, “The passing of such procedure and the extension of the GMP certificate validity for Farmak, a Ukrainian manufacturer, is a confirmation of the quality of medicinal products manufactured by the Company, as well as their marketing authorizations”.
Previous inspections by HALMED, the Croatian regulatory agency, were conducted at Farmak JSC in 2015. Following the inspections, the Company obtained the corresponding GMP certificates.
The 6th Conference of Farmak School of Young Scientists was held on 1 November 2018. 130 guests and employees of Farmak JSC attended the event; 26 reports were presented. This conference already enjoys popularity among students, young scientists, and post-graduate students. The School of Young Scientists is a platform for presenting scientific achievements a...
The strategic goal of Farmak JSC is to expand exports to the EU and to enter new markets Imposition of sanctions on Farmak JSC will not affect the company’s strategy and operations. Farmak JSC represents our state with dignity in the international arena: the company’s products are marketed in more than 20 countries of the […]
Farmak JSC received a Letter of gratitude from the Chairman of Committee on Public Health of the Verkhovna Rada of Ukraine for timely assistance during the elimination of the emergency situation in Chernihiv region caused by the explosion of ammunition warehouses near the town of Ichnia. Farmak often receives letters of gratitude as it always […]